Corvus Pharmaceuticals (CRVS) Preferred Stock Liabilities (2015)

Corvus Pharmaceuticals' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $125.8 million for Q4 2015.

• In Q4 2015, Preferred Stock Liabilities changed N/A year-over-year to $125.8 million; the TTM figure through Dec 2015 stood at $125.8 million (changed N/A YoY), while the FY2015 annual figure was $125.8 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q4 2015 stood at $125.8 million.
• The five-year high for Preferred Stock Liabilities was $125.8 million in Q4 2015, with the low at $125.8 million in Q4 2015.